These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6597712)

  • 41. Early idiopathic hemochromatosis with absent stainable bone marrow iron stores.
    Blitzer BL; Weiss GB; Osbaldiston GW; Markham RB; Aamodt R; Berk PD; Wolff SM; Fauci AS
    Gastroenterology; 1978 Nov; 75(5):886-8. PubMed ID: 81158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Idiopathic hemochromatosis. A hereditary defect in the regulation of iron metabolism].
    Hauge A
    Tidsskr Nor Laegeforen; 1982 Sep; 102(26):1332-4. PubMed ID: 7164080
    [No Abstract]   [Full Text] [Related]  

  • 44. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
    Milman N; Fenger K; Graudal NA; Nielsen LS
    Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterozygosity for the H63D mutation in the hereditary hemochromatosis (HFE) gene may lead into severe iron overload in beta-thalassemia minor: observations in a thalassemic kindred.
    Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Sánchez-Anzaldo J; Ruiz-Delgado GJ; Jiménez-González C; Carrera B
    Rev Invest Clin; 2001; 53(2):117-20. PubMed ID: 11421105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ascorbic acid safety: analysis of factors affecting iron absorption.
    Bendich A; Cohen M
    Toxicol Lett; 1990 Apr; 51(2):189-201. PubMed ID: 2184546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histocompatibility antigens as markers of abnormal iron metabolism in idiopathic hemochromatosis.
    Lloyd DA; Adams P; Sinclair NR; Stiller CR; Valberg LS
    Can Med Assoc J; 1978 Nov; 119(9):1051-6. PubMed ID: 84705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism in haemolytic states.
    Benöhr HC; Waller HD
    Clin Haematol; 1975 Feb; 4(1):45-62. PubMed ID: 126835
    [No Abstract]   [Full Text] [Related]  

  • 49. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
    Barton JC; Lee PL; West C; Bottomley SS
    Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemochromatosis and iron needs.
    Halliday JW
    Nutr Rev; 1998 Feb; 56(2 Pt 2):s30-7; discussion s54-75. PubMed ID: 9564175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Reduced deformability of erythrocytes as a common denominator of hemolytic anemias].
    Tillmann W
    Wien Med Wochenschr; 1986; 136 Spec No():14-6. PubMed ID: 3548086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of iron overload on ascorbic acid metabolism.
    Wapnick AA; Lynch SR; Krawitz P; Seftel HC; Charlton RW; Bothwell TH
    Br Med J; 1968 Sep; 3(5620):704-7. PubMed ID: 5673960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Erythrocyte pyruvate kinase deficiency in an old-order Amish cohort: longitudinal risk and disease management.
    Rider NL; Strauss KA; Brown K; Finkenstedt A; Puffenberger EG; Hendrickson CL; Robinson DL; Muenke N; Tselepis C; Saunders L; Zoller H; Morton DH
    Am J Hematol; 2011 Oct; 86(10):827-34. PubMed ID: 21815188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hemochromatosis and puryvate kinase deficiency (author's transl)].
    Noël D; Duron F; Thomas M
    Ann Med Interne (Paris); 1979 Dec; 130(12):679-83. PubMed ID: 539687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hereditary hemochromatosis].
    Dantas W
    Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [From gene to disease; hereditary non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency].
    de Vooght KM; van Wijk R; Nieuwenhuis HK; Ploos van Amstel JK; Rijksen G; van Solinge WW
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1828-31. PubMed ID: 12382367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Iron overload in mild sideroblastic anaemias.
    Peto TE; Pippard MJ; Weatherall DJ
    Lancet; 1983 Feb; 1(8321):375-8. PubMed ID: 6130377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is the HLA-linked haemochromatosis allele implicated in idiopathic refractory sideroblastic anaemia?
    Simon M; Beaumont C; Briere J; Brissot P; Deugnier Y; Edan G; Fauchet R; Garo G; Ghandour C; Grolleau J
    Br J Haematol; 1985 May; 60(1):75-80. PubMed ID: 3873956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early detection of genetic hemochromatosis: should all young adults be offered the genetic test?
    Worwood M
    Genet Test; 2000; 4(2):219-28. PubMed ID: 10953963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Familial iron overload with possible autosomal dominant inheritance.
    Eason RJ; Adams PC; Aston CE; Searle J
    Aust N Z J Med; 1990 Jun; 20(3):226-30. PubMed ID: 2372272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.